Biotech Values

[oc631]

ITMN’s revelation that ITMN-191 had serious toxicity problems occurred in Nov 2009

Your point is well taken but what was the lag between the time Roche/ITMN saw these problems in the lab and the time it was revealed to the public. To this day most investors still think the troubles with ITMN-191 may be resolved through dosing. Roche may have already decided that ITMN-191 is history. At what time do you think they will get around to telling us?